Scientists find way to convert bad body fat into good fat

There's good fat and bad fat in our bodies. The good fat helps burn calories, while the bad fat hoards calories, contributing to weight gain and obesity. Now, new research at Washington University School of Medicine in St. Louis has identified a way to convert bad, white fat into good, brown fat, at least in mice.

The findings raise the prospect of developing more effective treatments, in people, for obesity and diabetes related to weight gain.

The study is published Sept. 19 in the journal Cell Reports.

White fat stores calories and pads our bellies, hips and thighs. In contrast, brown fat, found near our necks and shoulders, burns calories through a process that generates heat.

The researchers found that blocking the activity of a specific protein in white fat triggered the fat to begin to brown into beige fat, a type of fat in between white and brown. Blocking the protein to create beige fat caused the fat cells to heat up and burn calories.

"Our goal is to find a way to treat or prevent obesity," said first author Irfan J. Lodhi, PhD. "Our research suggests that by targeting a protein in white fat, we can convert bad fat into a type of fat that fights obesity."

Beige fat was discovered in adult humans in 2015. Though it is almost like an intermediary between white fat and brown fat, Lodhi, an assistant professor of medicine in the Division of Endocrinology, Metabolism and Lipid Research, said it functions more like brown fat and can protect against obesity.

His team conducted a series of experiments in mice, creating a genetic strain of animals that didn't make a key protein in their white fat cells. Those mice had more beige fat and were leaner than their littermates, even when they ate the same amount of food as other mice. They also burned more calories.

"Mice normally have very low levels of the protein, called PexRAP, in their brown fat," he said. "When we put the mice into a cold environment, levels of the protein also decreased in white fat, allowing that fat to behave more like brown fat. Cold induces brown and beige fats to burn stored energy and produce heat."

When Lodhi's team blocked PexRAP in the animals, the mice converted white fat into beige fat that could burn calories.

More than two-thirds of adults in the United States are either overweight or obese. Some 30 million people have diabetes. These findings study suggest that if therapies could help convert their bad fat into good fat, those numbers might start to decline.

Lodhi said if the PexRAP protein could be blocked safely in white fat cells in humans, people might have an easier time losing weight.

"The challenge will be finding safe ways to do that without causing a person to overheat or develop a fever, but drug developers now have a good target," he said.

Lodhi IJ, Dean JM, He A, Park H, Tan M, Feng C, Song H, Hsu FF, Semenkovich CF.
PexRAP inhibits PRDM16-mediated thermogenic gene expression.
Cell Reports 20, 2766-2774. doi: 10.1016/j.celrep.2017.08.077.

Most Popular Now

FDA awards 15 grants for clinical trials to stimul…

The U.S. Food and Drug Administration today announced that it has awarded 15 new clinical trial research grants totaling more than $22 million over the next four years to...

A need for bananas? Dietary potassium regulates ca…

Bananas and avocados - foods that are rich in potassium - may help protect against pathogenic vascular calcification, also known as hardening of the arteries. University ...

Amgen and CytomX Therapeutics announce strategic c…

Amgen (NASDAQ:AMGN) and CytomX Therapeutics, Inc., (NASDAQ:CTMX) today announced that the companies have entered into a strategic collaboration in immuno-oncology. The co...

Roche launches NAVIFY Tumor Board solution to prov…

Roche (SIX: RO, ROG; OTCQX:RHHBY), has announced the launch of the NAVIFY Tumor Board solution, a clinical workflow and decision support software that optimises decision-...

Tagrisso granted breakthrough therapy designation …

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for Tagrisso (osimertinib) for the 1st-line treatm...

Pfizer launches novel programs to put important su…

Pfizer today unveils enhanced offerings to help patients manage their life with cancer. Pfizer Oncology Together is a first-of-its-kind program for patients taking Pfizer...

Novartis and UC Berkeley collaborate to tackle 'un…

Novartis has joined forces with researchers from the University of California, Berkeley, to develop new technologies for the discovery of next-generation therapeutics, pu...

Printed meds could reinvent pharmacies, drug resea…

A technology that can print pure, ultra-precise doses of drugs onto a wide variety of surfaces could one day enable on-site printing of custom-dosed medications at pharma...

Amgen and Simcere announce strategic collaboration…

Amgen (NASDAQ: AMGN) and Simcere Pharmaceutical Group have announced the execution of an exclusive agreement to co-develop and commercialize four biosimilars in China. Th...

IDF and Novo Nordisk launch first-ever global surv…

To mark World Heart Day today, the International Diabetes Federation (IDF) has partnered with Novo Nordisk to launch the first-ever multi-country online survey investigat...

FDA awards six grants for natural history studies …

The U.S. Food and Drug Administration today announced it has awarded six new research grants for natural history studies in rare diseases. The aim of the research is to i...

Indian government needs to do more to tackle risin…

In India, the sale of antibiotics requiring the tightest control and regulation is rising the fastest, according to an analysis by researchers at Queen Mary University of...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]